title: Prolonged Cardiac Dysfunction After Intraparenchymal Hemorrhage and Neurogenic Stunned Myocardium.
abstract: Cardiac dysfunction occurring secondary to neurologic disease, termed neurogenic stunned myocardium, is an incompletely understood phenomenon that has been described after several distinct neurologic processes. We present a case of neurogenic stunned myocardium, discovered intraoperatively after anesthetic induction, in a patient who presented to our operating room with a recent intraparenchymal hemorrhage. We discuss the longitudinal cardiac functional course after neurogenic stunned myocardium. Finally, we discuss the pathophysiology of neurogenic stunned myocardium, as well as its implications for anesthesiologists caring for neurosurgical patients.
authors.affiliation: From the *Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington; and †The Ohio State College of Medicine, Columbus, Ohio.
authors.forename: Vijay
authors.initials: V
authors.lastname: Krishnamoorthy
authors.forename: Thomas
authors.initials: T
authors.lastname: Wilson
authors.forename: Deepak
authors.initials: D
authors.lastname: Sharma
authors.forename: Monica S
authors.initials: MS
authors.lastname: Vavilala
mesh_terms: D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects*; D002543:Cerebral Hemorrhage / Q000150:complications* / Q000601:surgery; D004636:Emergency Service, Hospital; D006321:Heart / Q000503:physiopathology*; D020786:Hemangioma, Cavernous, Central Nervous System / Q000150:complications / Q000601:surgery; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy; D000077287:Levetiracetam; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects; D017682:Myocardial Stunning / Q000150:complications*; D009529:Nicardipine / Q000627:therapeutic use; D059035:Perioperative Period; D010656:Phenylephrine / Q000627:therapeutic use; D010889:Piracetam / Q000031:analogs & derivatives / Q000627:therapeutic use; D012640:Seizures / Q000517:prevention & control; D019966:Substance-Related Disorders / Q000150:complications; D054549:Takotsubo Cardiomyopathy / Q000175:diagnosis / Q000209:etiology*
chemical_list: D010656:Phenylephrine; D008694:Methamphetamine; D000077287:Levetiracetam; D009529:Nicardipine; D010889:Piracetam